We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$229M
Cap. Flow
-$115M
Cap. Flow %
-7.69%
Top 10 Hldgs %
22.33%
Holding
2,451
New
741
Increased
498
Reduced
386
Closed
708

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$48.3M
2
COL
Rockwell Collins
COL
+$34.6M
3
DELL icon
Dell
DELL
+$33.7M
4
CA
CA, Inc.
CA
+$33.7M
5
NXPI icon
NXP Semiconductors
NXPI
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 11.52%
2 Communication Services 10.15%
3 Healthcare 7.28%
4 Consumer Discretionary 5.72%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TENB icon
1551
Tenable Holdings
TENB
$4.01B
$6K ﹤0.01%
274
-743
-73% -$21.1K
WAL icon
1552
Western Alliance Bancorporation
WAL
$8.87B
$6K ﹤0.01%
+146
New +$6.9K
WBS icon
1553
Webster Financial
WBS
$12.8B
$6K ﹤0.01%
127
+9
+8% +$514
WEC icon
1554
WEC Energy
WEC
$35.1B
$6K ﹤0.01%
+89
New +$6.25K
WU icon
1555
Western Union
WU
$2.21B
$6K ﹤0.01%
+329
New +$5.98K
XHR
1556
Xenia Hotels & Resorts
XHR
$1.79B
$6K ﹤0.01%
+350
New +$7.11K
ZTS icon
1557
Zoetis
ZTS
$30B
$6K ﹤0.01%
+70
New +$6.3K
ZWS icon
1558
Zurn Elkay Water Solutions
ZWS
$8.53B
$6K ﹤0.01%
507
-34,829
-99% -$452K
JOYY
1559
JOYY Inc
JOYY
$3.75B
$6K ﹤0.01%
100
-22,700
-100% -$1.48M
TVRD
1560
Tvardi Therapeutics
TVRD
$23.4M
$6K ﹤0.01%
+13
New +$8.39K
CNSL
1561
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$6K ﹤0.01%
634
-24,766
-98% -$305K
BIG
1562
DELISTED
Big Lots, Inc.
BIG
$6K ﹤0.01%
203
-1,187
-85% -$46.2K
NEWR
1563
DELISTED
New Relic, Inc.
NEWR
$6K ﹤0.01%
78
+52
+200% +$4.38K
NATI
1564
DELISTED
National Instruments Corp
NATI
$6K ﹤0.01%
126
-74
-37% -$3.45K
SPPI
1565
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$6K ﹤0.01%
715
-23,335
-97% -$297K
AUD
1566
DELISTED
Audacy, Inc.
AUD
$6K ﹤0.01%
+1,123
New +$7.47K
RFP
1567
DELISTED
Resolute Forest Products Inc.
RFP
$6K ﹤0.01%
778
RDUS
1568
DELISTED
Radius Health, Inc.
RDUS
$6K ﹤0.01%
362
-382
-51% -$6.43K
CDK
1569
DELISTED
CDK Global, Inc.
CDK
$6K ﹤0.01%
+119
New +$6.28K
MRLN
1570
DELISTED
Marlin Business Services Corp
MRLN
$6K ﹤0.01%
267
COR
1571
DELISTED
Coresite Realty Corporation
COR
$6K ﹤0.01%
+65
New +$6.31K
FLXN
1572
DELISTED
Flexion Therapeutics, Inc.
FLXN
$6K ﹤0.01%
+524
New +$8.22K
CATM
1573
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$6K ﹤0.01%
+220
New +$6.67K
AXE
1574
DELISTED
Anixter International Inc
AXE
$6K ﹤0.01%
113
+100
+769% +$6.29K
AVX
1575
DELISTED
AVX Corporation
AVX
$6K ﹤0.01%
+380
New +$6.13K

Similar funds

Prelude Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Prelude Capital Management held 2,451 positions worth $1.49B, down 13% from $1.72B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management withdrew a net $115M in Q4 2018, closing 708 positions and reducing 386 holdings. Its most notable exit was Aetna Inc, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 15% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Red Hat Inc worth $33.2M.

  • Prelude Capital Management's largest Q4 2018 buy was Red Hat Inc: 189,248 shares worth $33.2M.
  • Prelude Capital Management added most to Athenahealth, Inc. in Q4 2018, an estimated $16M increase.
  • Prelude Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $33.7M.
  • Prelude Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $48.3M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.49B portfolio in Q4 2018.
  • Prelude Capital Management opened 741 new positions and closed 708 in Q4 2018.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.